MedTrace Logo

Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome

NCT03201068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2023-02-24

No results posted yet for this study

Summary

This study will define the impact of a probiotic supplement on microbiome, immune system, and metabolic syndrome. This study will determine the degree to which a probiotic supplement can 1) improve metabolic markers and metrics of metabolic syndrome, 2) alter microbiota composition and function, 3) impact microbiota metabolites, short-chain fatty acids-potential normalizers of metabolic and immune dysfunction, and 4) regulate immune status and function including reducing chronic, systemic inflammation as assessed by high dimensional immune profiling.

Conditions

  • Metabolic Syndrome
  • Microbiome
  • Immune Function
  • Inflammation

Interventions

DIETARY_SUPPLEMENT

Probiotic supplement

Probiotic supplement capsule

DIETARY_SUPPLEMENT

Placebo

Placebo capsule

Sponsors & Collaborators

Principal Investigators

  • Christopher D Gardner, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-14
Primary Completion
2018-11-16
Completion
2018-12-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03201068 on ClinicalTrials.gov